GJA1 and Parkinson disease: Moreover, in a Parkinson’s disease model, Cx43 immunoreactivity was elevated in astrocytes, glial cells and the methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine (MPTP)-lesioned striatum [30].